retatrutide phase 2 trial type 2 diabetes weight loss as a Novel Treatment for Obesity and Retatrutide Delivers Significant Hemoglobin A1C

You prioritize lean mass preservation

A mechanistic rationale for incretin-based therapeutics in the management of obesity

Words such as "believes", "expects", "anticipates", "may", "will", "should", "seeks", "approximately", "potential", "intends", "projects", "plans", "estimates" or the negative of these words or other comparable terminology (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements

What's next: Eli Lilly hasnt released a date for when it will seek approval by the Food and Drug Administration

22.Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials